Addex (ADXN) - Year-over-year net earnings per share growth for the last 12 months
Addex Therapeutics (ADXN) develops soft modulators for the treatment of dystonia and Parkinson's disease. This quarterly earnings per share chart demonstrates asset volatility, where the current metric is 18.40. The financial standing of the Swiss biotech is complicated by a lack of operating cash flow due to R&D expenditures. Future growth relies on cost optimization and the development of strategic neurobiological alliances.
Analytical breakdowns for Addex Therapeutics
- share price and consensus valuation forecast:
- market capitalization indicators:
- book capitalization indicators:
- business debt structure and liquidity details:
Total Debt to Capital Addex Therapeutics|ADXN - Long-Term Liabilities to Capital|Short-Term Debt to Equity Addex Therapeutics|ADXN - Aggregate Debt Obligations|Debts to Book Capitalization Addex Therapeutics, Ltd.|ADXN - Company Long-Term Debts|Company Short-Term Debt Addex Therapeutics|Quick Ratio addextherapeutics.com
- earnings and valuation multiples information:
ADXN - Company Net Income|Future Profit Addex Therapeutics|ADXN - P/E Multiple|Projected Price to Earnings Addex Therapeutics, Ltd.|ADXN - Company Value to Earnings Growth Ratio|EV/EBITDA Multiple Addex Therapeutics, Ltd.|ADXN - Operating income before deduction of amortization|Net earnings per share (EPS TTM) Addex Therapeutics|ADXN - Net earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months addextherapeutics.com|ADXN - Expected net earnings per share growth this year|Earnings growth forecast for next year Addex Therapeutics
Summary company analytics:Addex Therapeutics Ltd - ADXN
Addex Therapeutics (ADXN) is scaling the development of allosteric modulators through B2B partnerships to expand its footprint in the neuropharmaceuticals segment. Net income per share dynamics measure the efficiency of cash generation to cover liabilities, where steady growth confirms fundamental business resilience, while sharp spikes without a base signal risks, as clearly illustrated by the current quarterly EPS trend on the GURU.Markets platform.
Competitor analysis
BIIB (Biogen) - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last 12 months NBIX|Year-over-year net earnings per share growth for the last 12 months RGC|AXSM: Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months ACAD (ACADIA Pharmaceuticals)|Year-over-year earnings per share growth rate for the last twelve months XENE|Quarterly EPS earnings growth VKTX (Viking Therapeutics, Inc.)|Year-over-year earnings per one share growth for the last 12 months SUPN|Catalyst Pharmaceuticals Inc - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Denali Corp|Harmony Biosciences (HRMY) - Year-over-year earnings per share growth for the last twelve months|biohavenpharma.com - Year-over-year earnings per one share growth for the last 12 months|AMLX (Amylyx Pharmaceuticals, Inc.) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Trevi Therapeutics Inc|Year-over-year earnings per share growth for the last twelve months Praxis Medicines (PRAX)|AVXL: Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth CBLL (CeriBell, Inc.)|prothena.com (PRTA) - Earnings per share growth in annualized terms for the last twelve months|ALEC: Year-over-year net earnings per share growth for the last 12 months|ANNX - Quarterly EPS earnings growth|OMER (omeros.com) - Year-over-year net earnings per share growth for the last 12 months|NGNE: Year-over-year earnings per share growth rate for the last twelve months|ACIU (AC Immune) - Quarterly EPS earnings growth|voyagertherapeutics.com (VYGR) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth NMRA|Year-over-year net earnings per share growth for the last 12 months Scilex Holding SCLX|Year-over-year earnings per share growth for the last twelve months Tevogen Bio Holdings, Inc. TVGN|Year-over-year net earnings per share change for the last twelve months Alpha Cognition Inc (ACOG)|Cognition Therapeutics, Inc. - Quarterly EPS earnings growth|IKT - Quarterly EPS earnings growth|SAVA: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months ASRT|Year-over-year net earnings per share growth for the last 12 months COYA|Year-over-year earnings per share growth for the last 12 months VTGN (VistaGen Therapeutics Inc)|Year-over-year earnings per share growth for the last twelve months Ovid Therapeutics Inc. (OVID)|acumenpharm.com - Year-over-year earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months CervoMed CRVO|ATHE: Year-over-year earnings per share growth for the last 12 months|Clene Nanomedicine - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months PepGen Inc.|JUNS (Jupiter Neurosciences) - Year-over-year net earnings per share growth for the last 12 months|relmada.com (RLMD) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Annovis Bio|GRCE: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Firefly Neuroscience Inc (AIFF)|KLTO - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth NRSN (NeuroSense Therapeutics Ltd.)|Quarterly EPS earnings growth revivapharma.com RVPH|MetaVia, Inc. - Quarterly EPS earnings growth|NRXS (NeurAxis Inc.) - Year-over-year earnings per share growth for the last 12 months|HSDT: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months PASG|NEUP (Neuphoria Therapeutics, Inc.) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months minervaneurosciences.com NERV|Year-over-year net earnings per share growth for the last 12 months ATHA (Athira Pharma)|alzamend.com - Year-over-year earnings per share growth for the last 12 months|Cyclerion Therapeutics, Inc. - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months PTIX|KTTA: Year-over-year net earnings per share growth for the last 12 months|Cortigent, Inc. - Year-over-year earnings per share growth rate for the last twelve months|ATXI: Quarterly EPS earnings growth|Brainstorm Cell Therapeutics Inc. - Year-over-year earnings per one share growth for the last 12 months|CARA (Cara Therapeutics, Inc) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Chromocell CHRO|Year-over-year earnings per share growth for the last twelve months Eliem Therapeutics (ELYM)|ITCI (intracellulartherapies.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth LBPH (Longboard Pharmaceuticals, Inc.)|Quarterly EPS earnings growth Marinus Pharmaceuticals Inc MRNS|NKGN - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months NRBO|SAGE: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months synaptogen.com (SNPX)|Year-over-year net earnings per share growth for the last 12 months TRVN|Quarterly EPS earnings growth Vigil Neuro|Year-over-year net earnings per share growth for the last 12 months WENA (Anew Medical, Inc.)|Year-over-year earnings per share growth rate for the last twelve months CERE
